Leiomyosarcoma of the cervix uteri

Summary

Leiomyosarcoma of the cervix uteri (MONDO:0016283) is a disease and 1 clinical trial. A subtype of leiomyosarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
• Clinical trials: 1

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Annual incidence	<1 / 1 000 000		Worldwide	Validated

Identifiers

Disease identifiers

Field	Value
Canonical name	leiomyosarcoma of the cervix uteri
Mondo ID	MONDO:0016283
Orphanet	213807
NCIT	C128047
SNOMED CT	763771009
UMLS	C4289817
MedGen	927349
GARD	0020495
Anatomy (UBERON)	UBERON:0000002
Is cancer (heuristic)	no

Also known as: CELI · cervical leiomyosarcoma · leiomyosarcoma of uterine cervix · uterine cervix leiomyosarcoma

Disease family

This is a subtype of leiomyosarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system cancer › muscle cancer › smooth muscle cancer › leiomyosarcoma › leiomyosarcoma of the cervix uteri

Related subtypes (30): fallopian tube leiomyosarcoma, bone leiomyosarcoma, inflammatory leiomyosarcoma, conventional leiomyosarcoma, central nervous system leiomyosarcoma, colon leiomyosarcoma, heart leiomyosarcoma, ovary leiomyosarcoma, epithelioid leiomyosarcoma, lung leiomyosarcoma, myxoid leiomyosarcoma, small intestine leiomyosarcoma, cutaneous leiomyosarcoma, gallbladder leiomyosarcoma, esophagus leiomyosarcoma, gastric leiomyosarcoma, prostate leiomyosarcoma, vagina leiomyosarcoma, retroperitoneal leiomyosarcoma, breast leiomyosarcoma, vulvar leiomyosarcoma, kidney leiomyosarcoma, laryngeal leiomyosarcoma, mediastinum leiomyosarcoma, liver leiomyosarcoma, rectum leiomyosarcoma, pulmonary vein leiomyosarcoma, pulmonary artery leiomyosarcoma, superior vena cava leiomyosarcoma, leiomyosarcoma of the corpus uteri

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01793168	Not specified	RECRUITING	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford